Literature DB >> 11021555

Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study.

J J Wang1, S Foran, P Mitchell.   

Abstract

PURPOSE: To report age-specific prevalence and causes of bilateral and unilateral visual impairment in a representative older Australian population.
METHODS: Participants in the Blue Mountains Eye Study (n = 3654) underwent a detailed eye examination. Any visual impairment was defined as best-corrected visual acuity (VA) of 6/12 or worse, moderate impairment as VA 6/24-6/60 and severe impairment as VA worse than 6/60 (the Australian definition for legal blindness). Bilateral visual impairment was defined from the better eye and unilateral impairment from the worse eye. Proportional causes for visual loss were determined by the examining ophthalmologist.
RESULTS: Prevalence of bilateral and unilateral visual impairment was strongly age related. Corresponding bilateral and unilateral visual impairment prevalence rates were, respectively, 0.6% and 3.6% for persons aged 49-59 years, 1.1% and 8.2% for ages 60-69, 5.4% and 20.1% for ages 70-79, and 26.3% and 52.2% for persons aged 80+ years. Overwhelmingly, age-related maculopathy (ARM) was the predominant cause of bilateral blindness (13/17) and of moderate to severe bilateral visual impairment in persons aged 70+ years. However, cataract was the most frequent cause of mild bilateral visual impairment among persons aged 60+ years. Amblyopia was the most frequent cause of mild or worse unilateral visual impairment in persons aged 49-59 years. Cataract was the most common cause of mild unilateral visual impairment in people aged 60+ years, while ARM and cataract were jointly the most frequent causes of moderate to severe unilateral visual impairment in people aged 70+ years.
CONCLUSIONS: These findings indicate that around half of visually impaired persons aged 60 years or over had cataract, a cause amenable to treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11021555     DOI: 10.1046/j.1442-9071.2000.00315.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  49 in total

1.  A randomized trial of adding a plano lens to atropine for amblyopia.

Authors:  David K Wallace; Elizabeth L Lazar; Michael X Repka; Jonathan M Holmes; Raymond T Kraker; Darren L Hoover; Katherine K Weise; Amy L Waters; Melissa L Rice; Robert J Peters
Journal:  J AAPOS       Date:  2015-02       Impact factor: 1.220

2.  Prevalence of Amblyopia in School-Aged Children and Variations by Age, Gender, and Ethnicity in a Multi-Country Refractive Error Study.

Authors:  Ou Xiao; Ian G Morgan; Leon B Ellwein; Mingguang He
Journal:  Ophthalmology       Date:  2015-08-13       Impact factor: 12.079

3.  The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study.

Authors:  Jie Jin Wang; Robert J Ross; Jingsheng Tuo; George Burlutsky; Ava G Tan; Chi-Chao Chan; Emmanuel J Favaloro; Andrew Williams; Paul Mitchell
Journal:  Ophthalmology       Date:  2007-08-02       Impact factor: 12.079

4.  Unilateral reduced sense of smell is an early indicator for global olfactory loss.

Authors:  Volker Gudziol; Irene Paech; Thomas Hummel
Journal:  J Neurol       Date:  2010-01-03       Impact factor: 4.849

5.  Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

Authors:  Fridbert Jonasson; Diana E Fisher; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Tamara Harris; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

6.  The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters.

Authors:  Mari Elshout; Margriet I van der Reis; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-29       Impact factor: 3.117

7.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

8.  Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration.

Authors:  C Hopley; G Salkeld; P Mitchell
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

9.  Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the multi-ethnic pediatric eye disease study.

Authors: 
Journal:  Ophthalmology       Date:  2007-10-22       Impact factor: 12.079

10.  Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study.

Authors:  Silvana Artioli Schellini; Shane R Durkin; Erika Hoyama; Flavio Hirai; Ricardo Cordeiro; Robert J Casson; Dinesh Selva; Carlos Roberto Padovani
Journal:  BMC Ophthalmol       Date:  2009-08-19       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.